DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Modi S, Saura C, Yamashita T. et al.
Updated Results From DESTINY-Breast01, a Phase 2 Trial of Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Breast Cancer. SABCS 2020, Poster-Präsentation PD3-06.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.